Gainers

  • Jaguar Health IncJAGX shares rose 52.3 percent to $0.99 in pre-market trading after reporting a distribution, license and supply agreement with Knight therapeutics for Mytesi.
  • Ascena Retail Group, Inc.ASNA rose 21.5 percent to $4.87 in pre-market trading after the company reported stronger-than-expected results for its fourth quarter on Monday.
  • Tilray, Inc.TLRY rose 13.7 percent to $113.10 after declining 19.11 percent on Monday. Tilray disclosed that it has successfully exported medical cannabis from Canada To Australia.
  • Medigus Ltd.MDGS shares rose 11.3 percent to $3.95 in pre-market trading after climbing 12.70 percent on Monday.
  • Matinas BioPharma Holdings IncMTNB rose 11.1 percent to $0.70 in pre-market trading following Amarin’s positive trial outcome for Vascepa; Matinas’ MAT9001 showed clinical superiority to Vascepa in a 2015 study.
  • New Age Beverages Corporation NBEVshares rose 10.1 percent to $4.36 in pre-market trading after dropping 35.61 percent on Monday.
  • Geron Corporation GERNrose 7.4 percent to $6.66 in pre-market trading after surging 13.55 percent on Monday.
  • Randgold Resources Limited GOLDrose 5.3 percent to $71.72 in pre-market trading after falling 6.62 percent on Monday.
  • argenx SE ARGXrose 5.3 percent to $81.95 in pre-market trading.
  • IHS Markit LtdINFO rose 4.8 percent to $56.89 in pre-market trading after reporting upbeat results for its third quarter.
  • SAExploration Holdings, Inc.SAEX shares rose 4.2 percent to $29.90 in pre-market trading after jumping 284.34 percent on Monday.
  • Tenaris S.A.TS rose 4.5 percent to $34.48 in pre-market trading.
  • Aegon N.V.AEG shares rose 4.5 percent to $6.77 in pre-market.
  • Barrick Gold Corporation ABXrose 3.3 percent to $11.40 in pre-market trading after gaining 5.44 percent on Tuesday.

 

Losers

  • TG Therapeutics IncTGTX shares fell 32.4 percent to $6.25 in pre-market trading after the company issued an update regarding UNITY-CLL Phase 3 trial. The independent Data Safety Monitoring Board advised the company that interim analysis of overall response rate could not be conducted, as data were not sufficiently mature to conduct analysis.
  • Opiant Pharmaceuticals, Inc. (OPNT fell 15.6 percent to $18.00 in pre-market trading after reporting an offering of common shares.
  • New Concept Energy, Inc.GBR shares fell 8.3 percent to $3.11 in pre-market after surging 68.69 percent on Monday.
  • India Globalization Capital, Inc.IGC fell 7.7 percent to $2.40 in pre-market trading after dropping 10.34 percent on Monday.
  • Legacy Reserves LP LGCYfell 7.7 percent to $4.80 in pre-market trading.
  • Ashford IncAINC fell 6.7 percent to $80.00 in pre-market trading after reporting a $20 million common stock offering.
  • Ability Inc.ABIL shares fell 5.6 percent to $3.92 in pre-market trading after dropping 5.68 percent on Monday.
  • MBIA Inc.MBI shares fell 5.3 percent to $10.82 in pre-market trading.
  • Control4 Corporation CTRLshares fell 5.2 percent to $32.16 in pre-market trading.
  • FactSet Research Systems Inc.FDS fell 5.1 percent to $219.87 in pre-market trading after reporting downbeat Q4 results.
  • X Financial XYLfell 4.6 percent to $8.46 in pre-market trading after dropping 6.63 percent on Monday.
  • Ballard Power Systems Inc.BLDP fell 4.5 percent to $4.00 in pre-market trading after declining 3.90 percent on Monday.
  • CenturyLink, Inc.CTL shares fell 4 percent to $22.00 in pre-market trading after the company reported the resignation of its Chief Financial Officer Sunit Patel.
  • PetIQ IncPETQ fell 3.9 percent to $39.50 in pre-market trading after the company disclosed a 2 million share common stock offering and 3 million share common stock offering by selling shareholders.
  • CenterPoint Energy, Inc.CNP shares fell 3 percent to $27.00 in pre-market trading after the company reported commencement of $1.5 billion of common stock and 15,000,000 depositary shares.
  • Michael Kors Holdings LtdKORS fell 2.1 percent to $65.34 in pre-market trading after the company announced plans to acquire all outstanding shares of Versace for total enterprise value of $2.12 billion.